The search for the next wave of GLP-1s is pushing Big Pharma east, and China is quickly becoming the top destination to shop ...

"Lower dose does not mean lower responsibility." ...

The new drugs could become the way forward for medicated weight loss as clinical trials reveal optimistic results ...

GLP-1s are basically appetite’s off-switch: suddenly you’re “full” after three bites. Congrats on the smaller meals and ...

Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable ...

GLP-1 receptor agonist use appeared linked to significantly reduced all-cause mortality among people with sickle cell disease ...

By Tarun Sai Lomte From laboratory models to small human trials, a new review explores whether popular metabolic drugs could ...

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Company remains on track to submit Investigational Device Exemption (“IDE”), and if approved, commence U.S. clinical trials in 2026 to support a De Novo FDA application THE WOODLANDS, TX, Sept. 29, ...

Laboratories are no longer peripheral. They are central to modern clinical development - enabling earlier decision-making, ...